This proposal is based on our recent studies that have described a novel class of cell-secreted proteins, the """"""""protease nexins.' The nexins are secreted by a variety of cells including normal human foreskin fibroblast, vascular endothelial cells of bovine and human origin, and fibroblast-like cells derived from rodent embryos. The nexine function to monitor and regulate specific extracellular serine proteases through a mechanism that involves linkage to the specific protease, followed by cellular binding, internalization, and intracellular degradation of the protease nexin: protease complex. This process is mediated by cellular receptors specific for the nexins. We have identified three different protease nexins, PN-I (Mr 38,000), PN-II (Mr 95,000), and PN-III (Mr. 31,000), each of which show specificity for linkage to different serine proteases. My research plan is to purify two of the nexins (PN-I and PN-II) to homogeneity from the serum-free conditioned medium of human foreskin fibroblasts, raise antibodies to them, and develop radioimmunoassays for them. This will enable me to perform quantitative studies on their cellular release and biosynthesis. I also plan to generate peptide maps to determine if the different nexins are structurally related, as well as to study the site specific cleavage in the nexins upon interaction with their target proteases, and determine the role of this cleavage in the regulation of their cellular binding. In the final phases of my studies, I will conduct experiments to answer questions regarding the control of nexin biosynthesis and release. Since it is known that nexin release is stimulated by certain agents, including the proteases for which they show linkage specificity, I will try to identify the cellular receptor system that mediates this stimulation. Finally, I will address the question of specificity of the induction of nexin release, i.e., coordinate or individual, the determine if this regulation occurs at the level of transcription, translation, or some post-translational modification.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM034001-03S1
Application #
3284338
Study Section
Biochemistry Study Section (BIO)
Project Start
1984-07-01
Project End
1988-03-31
Budget Start
1987-08-01
Budget End
1988-03-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Crisp, Robert J; Knauer, Mary F; Knauer, Daniel J (2002) Protease nexin 1 is a potent urinary plasminogen activator inhibitor in the presence of collagen type IV. J Biol Chem 277:47285-91
Crisp, R J; Knauer, D J; Knauer, M F (2000) Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or intern J Biol Chem 275:19628-37
Knauer, D J; Majumdar, D; Fong, P C et al. (2000) SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J Biol Chem 275:37340-6
Knauer, M F; Crisp, R J; Kridel, S J et al. (1999) Analysis of a structural determinant in thrombin-protease nexin 1 complexes that mediates clearance by the low density lipoprotein receptor-related protein. J Biol Chem 274:275-81
Mentz, S; de Lacalle, S; Baerga-Ortiz, A et al. (1999) Mechanism of thrombin clearance by human astrocytoma cells. J Neurochem 72:980-7
Knauer, M F; Kridel, S J; Hawley, S B et al. (1997) The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J Biol Chem 272:29039-45
Knauer, M F; Hawley, S B; Knauer, D J (1997) Identification of a binding site in protease nexin I (PN1) required for the receptor mediated internalization of PN1-thrombin complexes. J Biol Chem 272:12261-4
Kridel, S J; Knauer, D J (1997) Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation. J Biol Chem 272:7656-60
Kridel, S J; Chan, W W; Knauer, D J (1996) Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III. J Biol Chem 271:20935-41
Smith, J W; Dey, N; Knauer, D J (1990) Heparin binding domain of antithrombin III: characterization using a synthetic peptide directed polyclonal antibody. Biochemistry 29:8950-7

Showing the most recent 10 out of 12 publications